Skip to main content

Advertisement

SpringerLink
Log in

The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Toll-like receptors (TLRs) play an important role in the induction and regulation of the innate immune system or adaptive immune responses. Genetic variations within human TLRs have been reported to be associated with a range of immune-related diseases. This study was conducted to investigate the frequencies of TLR3 rs3775290, TLR9 rs187084, and TLR10 rs4129009 polymorphisms and to detect between polymorphisms and autoantibody positive as RF, collagen type II, anti-RNP, and anti-CCP in patient group. We performed a case–control study of 100 rheumatoid arthritis (RA) cases and 100 healthy controls matched on age, sex, and residence. All polymorphisms in TLRs were determined by polymerase chain reaction-based restriction fragment length polymorphism. Serum autoantibody level was measured using quantitative ELISA. SNPs were genotyped in all samples. Our results showed that TT genotype for SNP 1237 T/C increased the RA risk significantly (p < 0.05). No statistically significant differences were found in the TLR3 and TLR10 genotypes or allele distribution between RA patients and control individuals. No associations were noted with autoantibody production and TLR3, TLR9, and TLR10 polymorphisms genotypes (p > 0.05). Our study suggests that a single nucleotide polymorphism (rs187084) in TLR9 gene may be a susceptibility factor for RA in Turkish population. Further studies are required to explore the role of TLRs gene polymorphisms in the risk of RA, especially in ethnically different populations to confirm our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N et al (2004) Expression of Toll-like receptor 2 on CD16 + blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50:1457–1467

    Article  PubMed  CAS  Google Scholar 

  2. Sobek V, Birkner N, Falk I, Wurch A, Kirschning CJ, Wagner H et al (2004) Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res Ther 6:433–446

    Article  Google Scholar 

  3. Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, Wagner U et al (2004) Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 172:1256–1265

    PubMed  CAS  Google Scholar 

  4. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T et al (2003) Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162:1221–1227

    Article  PubMed  CAS  Google Scholar 

  5. Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA et al (2003) Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48:642–650

    Article  PubMed  CAS  Google Scholar 

  6. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376

    Article  PubMed  CAS  Google Scholar 

  7. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987–995

    Article  PubMed  CAS  Google Scholar 

  8. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782–787

    Article  PubMed  CAS  Google Scholar 

  9. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145

    Article  PubMed  CAS  Google Scholar 

  10. Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14:432–436

    Article  PubMed  CAS  Google Scholar 

  11. Lawton JA, Ghosh P (2003) Novel therapeutic strategies based on toll-like receptor signaling. Curr Opin Chem Biol 7:446–451

    Article  PubMed  CAS  Google Scholar 

  12. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M et al (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745

    Article  PubMed  CAS  Google Scholar 

  13. Fuxman Bass JI, Gabelloni ML, Alvarez ME, Vermeulen ME, Russo DM, Zorreguieta A et al (2008) Characterization of bacterial DNA binding to human neutrophil surface. Lab Invest 288(9):926–937

    Article  Google Scholar 

  14. Pasare C, Medzhitov R (2005) Control of B-cell responses by toll-like receptors. Nature 438:364–368

    Article  PubMed  CAS  Google Scholar 

  15. Asselin-Paturel C, Trinchieri G (2005) Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 202:461–465

    Article  PubMed  CAS  Google Scholar 

  16. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440

    Article  PubMed  CAS  Google Scholar 

  17. Deng GM, Verdrengh M, Liu ZQ, Tarkowski A (2000) The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis Rheum 43:2283–2289

    Article  PubMed  CAS  Google Scholar 

  18. Miyata M, Kobayashi H, Sasajima T, Sato Y, Kasukawa R (2000) Unmethylated oligo-DNA containing CpG motifs aggravates collagen-induced arthritis in mice. Arthritis Rheum 43:2578–2582

    Article  PubMed  CAS  Google Scholar 

  19. Veiko NN, Shubaeva NO, Ivanova SM, Speranskii AI, Lyapunova NA, Spitkovskii DM (2005) Blood serum DNA in patients with rheumatoid arthritis is considerably enriched with fragments of ribosomal repeats containing immunostimulatory CpG-motifs. Bull Exp Biol Med 142(3):313–316

    Google Scholar 

  20. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al (2003) Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies (small star, filled). Genomics 81:85–91

    Article  PubMed  CAS  Google Scholar 

  21. Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C (2004) Crohn’s disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127:365–366

    Article  PubMed  Google Scholar 

  22. De Jager P, Richardson A, Vyse T, Rioux JS (2006) Genetic variation in Toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum 54:1279–1282

    Article  PubMed  Google Scholar 

  23. Berghofer B, Frommer T, Konig IR, Ziegler A, Chakraborty T, Bein G et al (2005) Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance. Clin Exp Allergy 35:1147–1154

    Article  PubMed  CAS  Google Scholar 

  24. Ito A, Ota M, Katsuyama Y, Inoko H, Ohno S, Mizuki N (2007) Lack of association of Toll-like receptor 9 gene polymorphism with Behçet’s disease in Japanese patients. Tissue Antigens 70(5):423–426

    Article  PubMed  CAS  Google Scholar 

  25. Carvalho A, Santos M, Maciel P, Rodrigues F (2008) T-1237C polymorphisms of TLR 9 gene is not associated with multiple sclerosis in the portuguese population. Mult Scler 14(4):550–552

    Article  PubMed  CAS  Google Scholar 

  26. Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C et al (2009) European Consortium on Rheumatoid Arthritis Families. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 11(1):R5

    Google Scholar 

  27. Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A, Schumann RR (2006) Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta 364:303–307

    Article  PubMed  CAS  Google Scholar 

  28. Novak N, Yu CF, Bussmann C, Maintz L, Peng WM, Hart J et al (2007) Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62(7):766–772

    Article  PubMed  CAS  Google Scholar 

  29. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607

    Article  PubMed  CAS  Google Scholar 

  30. Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR (2004) Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199:1631–1640

    Article  PubMed  CAS  Google Scholar 

  31. Szodoray P, Alex P, Frank MB, Turner M, Turner S, Knowlton N et al (2006) A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology 45:1466–1476

    Article  PubMed  CAS  Google Scholar 

  32. Rudnicka W, Burakowski T, Warnawin E, Jastrzebska M, Bik M, Kontny E et al (2009) Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients. Eur J Immunol 39(5):1211–1220

    Article  PubMed  CAS  Google Scholar 

  33. Barton GM, Miedzhitov R (2003) Toll-like receptor pathways. Science 300:1524–1525

    Article  PubMed  CAS  Google Scholar 

  34. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H (2000) Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 192:595–600

    Article  PubMed  CAS  Google Scholar 

  35. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF (1998) A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588–593

    Article  PubMed  CAS  Google Scholar 

  36. Matsumoto M, Funami K, Oshiumi H, Seya T (2004) Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 48:147–154

    PubMed  CAS  Google Scholar 

  37. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732–738

    Article  PubMed  CAS  Google Scholar 

  38. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S et al (2005) Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174:2942–2950

    PubMed  CAS  Google Scholar 

  39. Chuang T, Ulevitch R (2001) Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 1518:157–161

    PubMed  CAS  Google Scholar 

  40. Bernasconi N, Onai N, Lanzavecchia A (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101:4500–4504

    Article  PubMed  CAS  Google Scholar 

  41. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, Arinami T (2004) An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34:177–183

    Article  PubMed  CAS  Google Scholar 

  42. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T, Esterhuizen TM (2005) Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 66:125–130

    Article  PubMed  CAS  Google Scholar 

  43. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S (2007) Toll like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Opthalmol 91:962–965

    Article  Google Scholar 

  44. Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J, Vogelberg C, Weiland SK, von Mutius E, Kabesch M (2008) Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 122(1):86–92

    Article  PubMed  CAS  Google Scholar 

  45. Stevens VL, Hsing AW, Talbot JT, Zheng SL, Sun J, Chen J, Thun MJ, Xu J, Calle EE, Rodriguez C (2008) Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer 123(11):2644–2650

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Biology and Genetic Department, Firat University Hospital, Firat University, Elazig, Turkey

    Ebru Onalan Etem & Halit Elyas

  2. Physical Medicine and Rehabilitation, Firat University Hospital, Firat University, Elazig, Turkey

    Salih Ozgocmen & Arefe Yıldırım

  3. Immunology, Firat University Hospital, Firat University, Elazig, Turkey

    Ahmet Godekmerdan

Authors
  1. Ebru Onalan Etem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halit Elyas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salih Ozgocmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arefe Yıldırım
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmet Godekmerdan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ebru Onalan Etem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Etem, E.O., Elyas, H., Ozgocmen, S. et al. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int 31, 1369–1374 (2011). https://doi.org/10.1007/s00296-010-1472-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1472-8

Keywords

Search

Navigation